Abstract
The metabolic syndrome (MS) has a high prevalence in different countries (∼ 10% in France). It associates in the same subject central obesity, decrease in HDL cholesterol, increase in plasma triglycérides, glucose intolerance and hypertension. Insulin-resistance is a common feature even though it has been excluded from the more recent definitions because of the difficulty to assess it in clinical practice. Physiopathology of MS is not univocal. Stress, insulin resistance, central obesity are concerned. Marine omega 3 fatty acids (EPA and DHA) have demonstrated in many studies in rodents and some studies in humans their potentiality to prevent and treat MS, by their insulin-sensitizing effect, their ability to modulate mental stress response, to decrease plasma triglycerides, to reduce lipotoxicity, to slow down atherogenesis, to decrease oxidative stress and to ameliorate endothelial dysfunction. Additional studies are required to definitively confirm their usefulness and define their optimal daily amount for prevention and treatment beside physical activity, maintenance or reduction of body weight and pharmacological therapy of specific components of MS.
Keywords: Insulin resistance, non esterified fatty acids, Hypertriglyceridaemia, visceral adipose tissue, VLDL Production
Current Nutrition & Food Science
Title: Can Marine Omega 3 Fatty Acids Prevent and/or Treat Metabolic Syndrome?
Volume: 3 Issue: 2
Author(s): J. Delarue, V. Le Guen, G. Allain, C. Corporeau and S. Guillerm
Affiliation:
Keywords: Insulin resistance, non esterified fatty acids, Hypertriglyceridaemia, visceral adipose tissue, VLDL Production
Abstract: The metabolic syndrome (MS) has a high prevalence in different countries (∼ 10% in France). It associates in the same subject central obesity, decrease in HDL cholesterol, increase in plasma triglycérides, glucose intolerance and hypertension. Insulin-resistance is a common feature even though it has been excluded from the more recent definitions because of the difficulty to assess it in clinical practice. Physiopathology of MS is not univocal. Stress, insulin resistance, central obesity are concerned. Marine omega 3 fatty acids (EPA and DHA) have demonstrated in many studies in rodents and some studies in humans their potentiality to prevent and treat MS, by their insulin-sensitizing effect, their ability to modulate mental stress response, to decrease plasma triglycerides, to reduce lipotoxicity, to slow down atherogenesis, to decrease oxidative stress and to ameliorate endothelial dysfunction. Additional studies are required to definitively confirm their usefulness and define their optimal daily amount for prevention and treatment beside physical activity, maintenance or reduction of body weight and pharmacological therapy of specific components of MS.
Export Options
About this article
Cite this article as:
Delarue J., Le Guen V., Allain G., Corporeau C. and Guillerm S., Can Marine Omega 3 Fatty Acids Prevent and/or Treat Metabolic Syndrome?, Current Nutrition & Food Science 2007; 3 (2) . https://dx.doi.org/10.2174/157340107780598663
DOI https://dx.doi.org/10.2174/157340107780598663 |
Print ISSN 1573-4013 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3881 |
Call for Papers in Thematic Issues
Bioactive compounds, functional foods, metabolism, and health
Nutrition, metabolism, and their intervention strategies have become focal points of interest in the study of metabolic syndrome and health. Bioactive compounds, phytochemicals, and functional foods play crucial roles in modulating metabolic processes and improving human health. Moreover, the composition of the gut microbiome is also believed to be closely ...read more
Functional Foods in Human Health and Beyond
Foods are important source of nutrients including carbohydrates, proteins, lipids and other minerals. Furthermore, the functional foods are those agents that have additional components that are essential supports to the body in terms of antioxidant and pharmacologically active agents. The predominant functional foods are of plant in origin, whereas some ...read more
Harnessing Bioactive Compounds from Food Waste: Sustainable Extraction Strategies and Health Applications
Food waste presents a significant challenge across the postharvest cycle, from agricultural production to distribution. However, within this waste lies a treasure trove of bioactive chemicals that hold immense potential for nutraceuticals, functional foods, and postharvest additives, including antimicrobials. Various extraction methods, such as solvent extraction (SE), supercritical fluid extraction ...read more
Natural Bioactive Compounds Derivatives in Nutraceutical and Food Science
In the last years, plants have been widely used for their numerous properties and now there is growing interest in the study of classes of compounds obtained from plant species or derived from them. The importance of these natural compounds lies in their important therapeutic purposes, and in their capability ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Immune-Neuroendocrine Interactions Involving Thymus and Pineal Gland in Stem Cell Therapy of Age-Related Diseases
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Statin Drugs, Metabolic Pathways, and Asthma: A Therapeutic Opportunity Needing Further Research
Drug Metabolism Letters Utility of Intrapartum Transabdominal Ultrasound for the Correct Placement of Vacuum during Assisted Delivery
Current Women`s Health Reviews Impact of High Protein Intake on Viral Load and Hematological Parameters in HIV-infected Patients
Current HIV Research Life and Death Partners in Post-PCI Restenosis: Apoptosis, Autophagy, and The Cross-talk Between Them
Current Drug Targets The Potential Role of Antioxidants in Metabolic Syndrome
Current Pharmaceutical Design In the Search of the Vulnerable Plaque: Current Diagnostic Techniques and Future Directions
Vascular Disease Prevention (Discontinued) Biologic Therapy in Immune Mediated Inflammatory Disease: Basic Science and Clinical Concepts
Current Drug Safety Managing Bleeding Complications in Patients Treated with the Old and the New Anticoagulants
Current Pharmaceutical Design Cancer Nanotechnology: Emerging Role of Gold Nanoconjugates
Anti-Cancer Agents in Medicinal Chemistry Predicting Protein-Ligand Interactions Based on Chemical Preference Features with its Application to New D-Amino Acid Oxidase Inhibitor Discovery
Current Pharmaceutical Design Anabolic-androgenic Steroid use and Psychopathology in Athletes. A Systematic Review
Current Neuropharmacology Temporally and Spatially Restricted Gene Expression Profiling
Current Genomics Pulmonary Hypertension in the Critically Ill
Current Hypertension Reviews Experimental Rodent Models of Vascular Dementia: A Systematic Review
CNS & Neurological Disorders - Drug Targets Risk Factors for Lung Cancer in Never Smokers: A Recent Review Including Genetics
Current Respiratory Medicine Reviews Intra-uterine Growth Retardation as a Risk Factor of Postnatal Metabolic Disorders
Current Pharmaceutical Biotechnology Imaging the Role of Inflammation in Mood and Anxiety-related Disorders
Current Neuropharmacology Cholesterol Oxidation Products and Disease: An Emerging Topic of Interest in Medicinal Chemistry
Current Medicinal Chemistry Editorial (Hot Topic: Achieving Current Goals in Prevention and Treatment of Vascular Disease: An Update)
Current Pharmaceutical Design